Status: Not yet recruiting
Duodenal pulsENDO as an Early Treatment for Type 2 DM
This study is designed to evaluate the efficacy and safety of endoscopic duodenal re-cellularization therapy using pulsed electric field in individuals with in patients with a recent diagnosis of type 2 diabetes mellitus (T2DM).
Participants needed: 40
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Chinese University of Hong KongUpdated: Jun 24, 2026Locations: 1
Eligibility criteria
Duration of T2DM </= 2 years [+2]
Previous treatment with pulsENDO or similar procedure [+18]